Glucagon-Like Peptide-1 and the Islet β-Cell: Augmentation of Cell Proliferation and Inhibition of Apoptosis
- 1 December 2003
- journal article
- editorial
- Published by The Endocrine Society in Endocrinology
- Vol. 144 (12) , 5145-5148
- https://doi.org/10.1210/en.2003-1147
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human IsletsEndocrinology, 2003
- Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetesJournal of Molecular Medicine, 2003
- Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in KoreaJournal of Clinical Endocrinology & Metabolism, 2003
- Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5′-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent PathwayEndocrinology, 2003
- Monounsaturated Fatty Acids Prevent the Deleterious Effects of Palmitate and High Glucose on Human Pancreatic β-Cell Turnover and FunctionDiabetes, 2003
- β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 DiabetesDiabetes, 2003
- Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell ApoptosisJournal of Biological Chemistry, 2003
- A Novel Approach to Increase Human Islet Cell Mass While Preserving β-Cell FunctionDiabetes, 2002
- Glucagon-Like Peptide-1 Promotes Islet Cell Growth and Inhibits Apoptosis in Zucker Diabetic RatsEndocrinology, 2002
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999